Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000947871-25-000138·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
Sionna Therapeutics Inc
Common Stock · CUSIP: 829401108
Event date: 2025-02-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ORBIMED ADVISORS LLCReported CIK 0001055951
Shares: 3,704,959.00 · Class: 8.4%
- OrbiMed Capital GP VIII LLCReported CIK 0001845804
Shares: 3,704,959.00 · Class: 8.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-000138
- Form type
- SCHEDULE 13D
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Feb 13, 2025
- Reporting period
- Feb 10, 2025
- Description
- Schedule 13D beneficial ownership